Barriers in access to oncology drugs — a global crisis
Cet article présente les points de vue de 6 oncologues de 6 pays (Brésil, Etats-Unis, Inde, Malaisie, Pologne et Rwanda) sur les facteurs entravant l'accès aux anticancéreux et les solutions pour améliorer cet accès
In the past decade, oncologists worldwide have seen unprecedented advances in drug development and approvals but have also become increasingly cognizant of the rising costs of and increasing inequities in access to these therapies. These trends have resulted in the current problematic situation in which dramatic disparities in outcomes exist among patients with cancer worldwide owing, in part, to the lack of access to drugs that provide clinically meaningful benefits. In this Viewpoint, we have asked six oncologists working in different countries to describe how they perceive this issue in their region and propose potential solutions.
Nature Reviews Clinical Oncology , article en libre accès, 2022